Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats

Authors: Timothy M Straight, Martin G Ottolini, Gregory A Prince, Maryna C Eichelberger

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

Influenza virus infection or vaccination evokes an antibody response to viral hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins, which results in immunity against influenza A viruses of the same HA and NA subtype. A heterosubtypic immune response that offers some protection against different influenza A subtypes has been suggested from epidemiologic studies in human influenza outbreaks, and has been induced in experimental animal models. Original studies of such cross-protection showed that cytotoxic T lymphocytes (CTL) protect H3N2-immune mice from a lethal H1N1 infection. More recent studies in mice demonstrate that antibodies also contribute to heterosubtypic immunity (HSI). We previously demonstrated that HSI in cotton rats (Sigmodon hispidus) is characterized by protection of H3N2-immune animals from influenza H1N1-induced increase in respiratory rate (tachypnea). Alternatively, H1N1-immune animals are protected from H3N2-induced tachypnea. The experiments described in this report were designed to elucidate the immune mechanism that prevents this very early sign of disease.

Results

Our results show that cotton rats provided with H1N1-immune serum prior to challenge with an H3N2 virus were protected from influenza-associated tachypnea, with the degree of protection correlating with the antibody titer transferred. Immunization with an inactivated preparation of virus delivered intramuscularly also provided some protection suggesting that CTL and/or mucosal antibody responses are not required for protection. Antibodies specific for conserved epitopes present on the virus exterior are likely to facilitate this protection since prophylactic treatment of cotton rats with anti-M2e (the extracellular domain of M2) but not anti-nucleoprotein (NP) reduced virus-induced tachypnea.

Conclusion

In the cotton rat model of heterosubtypic immunity, humoral immunity plays a role in protecting animals from influenza-induced tachypea. Partial protection against respiratory disease caused by different influenza A subtypes can be attained with either live virus administered intranasally or inactivated virus delivered intramuscularly suggesting that either vaccine regimen may provide some protection against potential pandemic outbreaks in humans.
Appendix
Available only for authorised users
Literature
2.
go back to reference WHO: Recommended composition of influenza virus vaccines for use in the 2004–2005 influenza season. Weekly Epidemiol Rec 2004, 79: 88-92. WHO: Recommended composition of influenza virus vaccines for use in the 2004–2005 influenza season. Weekly Epidemiol Rec 2004, 79: 88-92.
3.
go back to reference Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD: Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an A/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J 2004, 23: 1053-5. 10.1097/01.inf.0000143643.44463.b1CrossRefPubMed Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD: Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an A/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J 2004, 23: 1053-5. 10.1097/01.inf.0000143643.44463.b1CrossRefPubMed
4.
go back to reference Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H: Cross-subtype protection in humans during sequential overlapping and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 1985, 151: 81-8.CrossRefPubMed Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H: Cross-subtype protection in humans during sequential overlapping and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 1985, 151: 81-8.CrossRefPubMed
5.
go back to reference Epstein SL: Prior H1N1 Influenza Infection and Susceptibility of Cleveland family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature. J Infect Dis 2006, 193: 49-53. 10.1086/498980CrossRefPubMed Epstein SL: Prior H1N1 Influenza Infection and Susceptibility of Cleveland family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature. J Infect Dis 2006, 193: 49-53. 10.1086/498980CrossRefPubMed
6.
go back to reference Webster RG, Askonas BA: Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 1980, 10: 396-401. 10.1002/eji.1830100515CrossRefPubMed Webster RG, Askonas BA: Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 1980, 10: 396-401. 10.1002/eji.1830100515CrossRefPubMed
7.
go back to reference Yewdell JW, Bennink JR, Smith GL, Moss B: Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1985, 82: 1785-9. 10.1073/pnas.82.6.1785PubMedCentralCrossRefPubMed Yewdell JW, Bennink JR, Smith GL, Moss B: Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1985, 82: 1785-9. 10.1073/pnas.82.6.1785PubMedCentralCrossRefPubMed
8.
go back to reference Tumpey TM, Renshaw M, Clements JD, Katz JM: Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 2001, 75: 5141-50. 10.1128/JVI.75.11.5141-5150.2001PubMedCentralCrossRefPubMed Tumpey TM, Renshaw M, Clements JD, Katz JM: Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 2001, 75: 5141-50. 10.1128/JVI.75.11.5141-5150.2001PubMedCentralCrossRefPubMed
9.
go back to reference Nguyen H, van Ginkel FW, Vu HL, McGhee JR, Mestecky J: Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic lymphocytes. J Infect Dis 2001, 183: 368-76. 10.1086/318084CrossRefPubMed Nguyen H, van Ginkel FW, Vu HL, McGhee JR, Mestecky J: Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic lymphocytes. J Infect Dis 2001, 183: 368-76. 10.1086/318084CrossRefPubMed
10.
go back to reference Bianchi E, Liang X, Ingallinella P, Finotto M, Chastain MA, Fan J, Fu TM, Song HC, Horton MS, Freed DC, Manger W, Wen E, Shi L, Ionescu R, Price C, Wenger M, Emini EA, Cortese R, Ciliberto G, Shiver JW, Pessi A: Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol 2005, 79: 7380-8. 10.1128/JVI.79.12.7380-7388.2005PubMedCentralCrossRefPubMed Bianchi E, Liang X, Ingallinella P, Finotto M, Chastain MA, Fan J, Fu TM, Song HC, Horton MS, Freed DC, Manger W, Wen E, Shi L, Ionescu R, Price C, Wenger M, Emini EA, Cortese R, Ciliberto G, Shiver JW, Pessi A: Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol 2005, 79: 7380-8. 10.1128/JVI.79.12.7380-7388.2005PubMedCentralCrossRefPubMed
11.
go back to reference Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR: Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990, 64: 1375-1377.PubMedCentralPubMed Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR: Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990, 64: 1375-1377.PubMedCentralPubMed
12.
go back to reference Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies ME, Liao J, Emini EA, Shiver JW: Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004, 22: 2993-3003. 10.1016/j.vaccine.2004.02.021CrossRefPubMed Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies ME, Liao J, Emini EA, Shiver JW: Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004, 22: 2993-3003. 10.1016/j.vaccine.2004.02.021CrossRefPubMed
13.
go back to reference Eichelberger MC, Prince GA, Ottolini MG: Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor. Virology 2004, 322: 300-7. 10.1016/j.virol.2004.01.032CrossRefPubMed Eichelberger MC, Prince GA, Ottolini MG: Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor. Virology 2004, 322: 300-7. 10.1016/j.virol.2004.01.032CrossRefPubMed
14.
go back to reference Straight TM, Ottolini MG, Prince GA, Eichelberger MC: Evidence of a cross-protective immune response to influenza A in the cotton rat model. Vaccine 2006, 24: 6264-71. 10.1016/j.vaccine.2006.05.092CrossRefPubMed Straight TM, Ottolini MG, Prince GA, Eichelberger MC: Evidence of a cross-protective immune response to influenza A in the cotton rat model. Vaccine 2006, 24: 6264-71. 10.1016/j.vaccine.2006.05.092CrossRefPubMed
15.
go back to reference Feng JQ, Mozdzanowska K, Gerhard W: Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol 2002, 76: 1369-78.PubMedCentralCrossRefPubMed Feng JQ, Mozdzanowska K, Gerhard W: Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol 2002, 76: 1369-78.PubMedCentralCrossRefPubMed
16.
go back to reference Slepushkin AN: The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull World Health Org 1959, 20: 297-301.PubMedCentralPubMed Slepushkin AN: The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull World Health Org 1959, 20: 297-301.PubMedCentralPubMed
17.
go back to reference Feng JQ, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W: Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 2006, 3: 102-115. 10.1186/1743-422X-3-102PubMedCentralCrossRefPubMed Feng JQ, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W: Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 2006, 3: 102-115. 10.1186/1743-422X-3-102PubMedCentralCrossRefPubMed
18.
go back to reference Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D: Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 2001, 211: 143-53. 10.1006/cimm.2001.1835CrossRefPubMed Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D: Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 2001, 211: 143-53. 10.1006/cimm.2001.1835CrossRefPubMed
19.
go back to reference Jegerlehner A, Schmitz N, Storni T, Bachmann MF: Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 2004, 172: 5598-605.CrossRefPubMed Jegerlehner A, Schmitz N, Storni T, Bachmann MF: Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 2004, 172: 5598-605.CrossRefPubMed
20.
go back to reference Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H: Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21: 3212-8. 10.1016/S0264-410X(03)00234-2CrossRefPubMed Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H: Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21: 3212-8. 10.1016/S0264-410X(03)00234-2CrossRefPubMed
21.
go back to reference Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB: Fluorometric assay of neuraminidase with a sodium(4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal Biochem 1979, 94: 287-96. 10.1016/0003-2697(79)90362-2CrossRefPubMed Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB: Fluorometric assay of neuraminidase with a sodium(4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal Biochem 1979, 94: 287-96. 10.1016/0003-2697(79)90362-2CrossRefPubMed
22.
go back to reference Ottolini MG, Blanco JCG, Eichelberger MC, Pletneva L, Richardson JY, Porter DD, Prince GA: Influenza pathogenesis in cotton rats: a useful small animal model for the study of disease and immunity. J Gen Virol 2005, 86: 2823-2830. 10.1099/vir.0.81145-0CrossRefPubMed Ottolini MG, Blanco JCG, Eichelberger MC, Pletneva L, Richardson JY, Porter DD, Prince GA: Influenza pathogenesis in cotton rats: a useful small animal model for the study of disease and immunity. J Gen Virol 2005, 86: 2823-2830. 10.1099/vir.0.81145-0CrossRefPubMed
Metadata
Title
Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats
Authors
Timothy M Straight
Martin G Ottolini
Gregory A Prince
Maryna C Eichelberger
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-44

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.